Mukka Proteins Limited (NSE:MUKKA)

Mukka Proteins Statistics

Total Valuation

Mukka Proteins has a market cap or net worth of INR 7.31 billion. The enterprise value is 13.06 billion.

Market Cap	7.31B
Enterprise Value	13.06B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Mukka Proteins has 300.00 million shares outstanding. The number of shares has increased by 12.29% in one year.

Current Share Class	300.00M
Shares Outstanding	300.00M
Shares Change (YoY)	+12.29%
Shares Change (QoQ)	-3.15%
Owned by Insiders (%)	73.33%
Owned by Institutions (%)	7.55%
Float	76.07M

Valuation Ratios

The trailing PE ratio is 15.37.

PE Ratio	15.37
Forward PE	n/a
PS Ratio	0.66
PB Ratio	1.58
P/TBV Ratio	1.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.19, with an EV/FCF ratio of -9.29.

EV / Earnings	27.63
EV / Sales	1.19
EV / EBITDA	12.19
EV / EBIT	14.02
EV / FCF	-9.29

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 1.32.

Current Ratio	1.38
Quick Ratio	0.24
Debt / Equity	1.32
Debt / EBITDA	5.67
Debt / FCF	-4.34
Interest Coverage	2.78

Financial Efficiency

Return on equity (ROE) is 11.25% and return on invested capital (ROIC) is 6.12%.

Return on Equity (ROE)	11.25%
Return on Assets (ROA)	5.46%
Return on Invested Capital (ROIC)	6.12%
Return on Capital Employed (ROCE)	19.43%
Revenue Per Employee	35.03M
Profits Per Employee	1.51M
Employee Count	314
Asset Turnover	1.03
Inventory Turnover	1.39

Taxes

In the past 12 months, Mukka Proteins has paid 154.36 million in taxes.

Income Tax	154.36M
Effective Tax Rate	23.85%

Stock Price Statistics

The stock price has decreased by -40.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-40.70%
50-Day Moving Average	25.23
200-Day Moving Average	29.04
Relative Strength Index (RSI)	43.70
Average Volume (20 Days)	1,795,197

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mukka Proteins had revenue of INR 11.00 billion and earned 472.63 million in profits. Earnings per share was 1.59.

Revenue	11.00B
Gross Profit	2.48B
Operating Income	936.12M
Pretax Income	647.09M
Net Income	472.63M
EBITDA	1.06B
EBIT	936.12M
Earnings Per Share (EPS)	1.59

Balance Sheet

The company has 529.78 million in cash and 6.10 billion in debt, giving a net cash position of -5.57 billion or -18.56 per share.

Cash & Cash Equivalents	529.78M
Total Debt	6.10B
Net Cash	-5.57B
Net Cash Per Share	-18.56
Equity (Book Value)	4.62B
Book Value Per Share	15.12
Working Capital	2.91B

Cash Flow

In the last 12 months, operating cash flow was -851.19 million and capital expenditures -553.93 million, giving a free cash flow of -1.41 billion.

Operating Cash Flow	-851.19M
Capital Expenditures	-553.93M
Free Cash Flow	-1.41B
FCF Per Share	-4.68

Margins

Gross margin is 22.54%, with operating and profit margins of 8.51% and 4.30%.

Gross Margin	22.54%
Operating Margin	8.51%
Pretax Margin	5.88%
Profit Margin	4.30%
EBITDA Margin	9.62%
EBIT Margin	8.51%
FCF Margin	n/a

Dividends & Yields

Mukka Proteins does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.29%
Shareholder Yield	-12.29%
Earnings Yield	6.46%
FCF Yield	-19.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3